Suppr超能文献

用于2型糖尿病控制和自我管理的移动健康应用程序:关于用户可接受性和接受度的定性研究

Mobile Health Apps for the Control and Self-management of Type 2 Diabetes Mellitus: Qualitative Study on Users' Acceptability and Acceptance.

作者信息

Bults Marloes, van Leersum Catharina Margaretha, Olthuis Theodorus Johannes Josef, Bekhuis Robin Enya Marije, den Ouden Marjolein Elisabeth Maria

机构信息

Technology, Health & Care Research Group, Saxion University of Applied Sciences, Enschede, Netherlands.

Science, Technology, and Policy Studies, Faculty of Behavioural, Management and Social Sciences, University of Twente, Enschede, Netherlands.

出版信息

JMIR Diabetes. 2023 Jan 24;8:e41076. doi: 10.2196/41076.

Abstract

BACKGROUND

Mobile health apps are promising tools to help patients with type 2 diabetes mellitus (T2DM) improve their health status and thereby achieve diabetes control and self-management. Although there is a wide array of mobile health apps for T2DM available at present, apps are not yet integrated into routine diabetes care. Acceptability and acceptance among patients with T2DM is a major challenge and prerequisite for the successful implementation of apps in diabetes care.

OBJECTIVE

This study provides an in-depth understanding of the perceptions of patients with T2DM before use (acceptability) and after use (acceptance) regarding 4 different mobile health apps for diabetes control and self-management.

METHODS

A descriptive qualitative research design was used in this study. Participants could choose 1 of the 4 selected apps for diabetes control and self-management (ie, Clear.bio in combination with FreeStyle Libre, mySugr, MiGuide, and Selfcare). The selection was based on a systematic analysis of the criteria for (functional) requirements regarding monitoring, data collection, provision of information, coaching, privacy, and security. To explore acceptability, 25 semistructured in-depth interviews were conducted with patients with T2DM before use. This was followed by 4 focus groups to discuss the acceptance after use. The study had a citizen science approach, that is, patients with T2DM collaborated with researchers as coresearchers. All coresearchers actively participated in the preparation of the study, data collection, and data analysis. Data were collected between April and September 2021. Thematic analysis was conducted using a deductive approach using AtlasTi9.

RESULTS

In total, 25 coresearchers with T2DM participated in this study. Of them, 12 coresearchers tested Clear, 5 MiGuide, 4 mySugr, and 4 Selfcare. All coresearchers participated in semistructured interviews, and 18 of them attended focus groups. Personal health was the main driver of app use. Most coresearchers were convinced that a healthy lifestyle would improve blood glucose levels. Although most coresearchers did not expect that they need to put much effort into using the apps, the additional effort to familiarize themselves with the app use was experienced as quite high. None of the coresearchers had a health care professional who provided suggestions on using the apps. Reimbursement from insurance companies and the acceptance of apps for diabetes control and self-management by the health care system were mentioned as important facilitating conditions.

CONCLUSIONS

The research showed that mobile health apps provide support for diabetes control and self-management in patients with T2DM. Integrating app use in care as usual and guidelines for health care professionals are recommended. Future research is needed on how to increase the implementation of mobile health apps in current care pathways. In addition, health care professionals need to improve their digital skills, and lifelong learning is recommended.

摘要

背景

移动健康应用程序是很有前景的工具,可帮助2型糖尿病(T2DM)患者改善健康状况,从而实现糖尿病控制和自我管理。尽管目前有大量针对T2DM的移动健康应用程序,但这些应用程序尚未融入常规糖尿病护理中。T2DM患者对其的可接受性和接受度是在糖尿病护理中成功应用这些应用程序的主要挑战和前提条件。

目的

本研究深入了解T2DM患者在使用4种不同的用于糖尿病控制和自我管理的移动健康应用程序之前(可接受性)和之后(接受度)的看法。

方法

本研究采用描述性定性研究设计。参与者可以从4种选定的用于糖尿病控制和自我管理的应用程序中选择1种(即Clear.bio与FreeStyle Libre结合、mySugr、MiGuide和Selfcare)。选择基于对监测、数据收集、信息提供、指导、隐私和安全方面(功能)要求标准的系统分析。为了探索可接受性,在使用前对25名T2DM患者进行了半结构化深度访谈。随后进行了4个焦点小组讨论使用后的接受度。该研究采用公民科学方法,即T2DM患者作为共同研究者与研究人员合作。所有共同研究者都积极参与了研究准备、数据收集和数据分析。数据于2021年4月至9月收集。使用AtlasTi9采用演绎法进行主题分析。

结果

共有25名患有T2DM的共同研究者参与了本研究。其中,12名共同研究者测试了Clear,5名测试了MiGuide,4名测试了mySugr,4名测试了Selfcare。所有共同研究者都参与了半结构化访谈,其中18人参加了焦点小组。个人健康是应用程序使用的主要驱动力。大多数共同研究者确信健康的生活方式会改善血糖水平。尽管大多数共同研究者预计自己在使用应用程序时不需要付出太多努力,但他们体验到熟悉应用程序使用的额外努力相当大。没有一名共同研究者有医疗保健专业人员就使用应用程序提供建议。保险公司的报销以及医疗保健系统对用于糖尿病控制和自我管理的应用程序的接受被提及为重要的促进条件。

结论

研究表明,移动健康应用程序为T2DM患者的糖尿病控制和自我管理提供了支持。建议将应用程序的使用融入常规护理以及为医疗保健专业人员制定指导方针。未来需要研究如何在当前护理路径中增加移动健康应用程序的实施。此外,医疗保健专业人员需要提高他们的数字技能,建议进行终身学习。

相似文献

3
Users' acceptability of a mobile application for persons with type 2 diabetes: a qualitative study.
BMC Health Serv Res. 2019 Sep 6;19(1):641. doi: 10.1186/s12913-019-4486-2.
6
Smartphone Users' Persuasion Knowledge in the Context of Consumer mHealth Apps: Qualitative Study.
JMIR Mhealth Uhealth. 2021 Apr 13;9(4):e16518. doi: 10.2196/16518.
8
Mobile health applications to assist patients with diabetes: lessons learned and design implications.
J Diabetes Sci Technol. 2012 Sep 1;6(5):1197-206. doi: 10.1177/193229681200600525.

引用本文的文献

1
Trust in Medical AI: The Case of mHealth Diabetes Apps.
J Eval Clin Pract. 2025 Aug;31(5):e70216. doi: 10.1111/jep.70216.
2
Enhancing Mobile App Adoption for Type 2 Diabetes Mellitus Medication Adherence and Self-Management: A Grounded Theory Study.
J Diabetes Sci Technol. 2025 Jun 21:19322968251349851. doi: 10.1177/19322968251349851.
3
Diabetes and Wellness Smartphone Applications for Self-Management among Adults With Diabetes in the United States.
J Diabetes Sci Technol. 2025 Mar 31:19322968251322189. doi: 10.1177/19322968251322189.
8
Assessing intention to use mobile phone-based self-management support among adults with type 2 diabetes in Saudi Arabia: A cross-sectional study.
Digit Health. 2025 Jan 10;11:20552076241308993. doi: 10.1177/20552076241308993. eCollection 2025 Jan-Dec.
10
A mobile health application use among diabetes mellitus patients: a systematic review and meta-analysis.
Front Endocrinol (Lausanne). 2024 Oct 11;15:1481410. doi: 10.3389/fendo.2024.1481410. eCollection 2024.

本文引用的文献

4
A Scoping Review and General User's Guide for Facilitating the Successful Use of eHealth Programs for Diabetes in Clinical Care.
Diabetes Technol Ther. 2021 Feb;23(2):133-145. doi: 10.1089/dia.2020.0383. Epub 2020 Aug 31.
5
Technology Acceptance in Mobile Health: Scoping Review of Definitions, Models, and Measurement.
J Med Internet Res. 2020 Jul 6;22(7):e17256. doi: 10.2196/17256.
6
Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends.
J Epidemiol Glob Health. 2020 Mar;10(1):107-111. doi: 10.2991/jegh.k.191028.001.
7
Acceptance of Mobile Health Applications: Examining Key Determinants and Moderators.
Front Psychol. 2019 Dec 10;10:2791. doi: 10.3389/fpsyg.2019.02791. eCollection 2019.
8
Dietary Intake and Type 2 Diabetes.
Nutrients. 2019 Sep 11;11(9):2177. doi: 10.3390/nu11092177.
9
Interventions for self-management of type 2 diabetes: An integrative review.
Int J Nurs Sci. 2018 Dec 14;6(1):70-91. doi: 10.1016/j.ijnss.2018.12.002. eCollection 2019 Jan 10.
10
Digital health technology and mobile devices for the management of diabetes mellitus: state of the art.
Diabetologia. 2019 Jun;62(6):877-887. doi: 10.1007/s00125-019-4864-7. Epub 2019 Apr 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验